[1] FATHI AT, WANDER SA, BLONQUIST TM, et al. Phase Ⅰ study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia[J]. Haematologica, 2017, 102(4): 719. doi: 10.3324/haematol.2016.158394
[2] HUANG M, HUANG J, ZHENG Y, et al. Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism[J]. Eur J Med Chem, 2019, 178: 259. doi: 10.1016/j.ejmech.2019.05.078
[3] SLEIMAN S, DRAGON F. Recent advances on the structure and function of RNA acetyltransferase Kre33/NAT10[J]. Cells, 2019, 8(9): 123.
[4] ZHANG X, CHEN J, JIANG S, et al. N-Acetyltransferase 10 enhances doxorubicin resistance in human hepatocellular carcinoma cell lines by promoting the epithelial-to-mesenchymal transition[J]. Oxid Med Cell Longev, 2019, 2019: 7561879.
[5] BALMUS G, LARRIEU D, BARROS AC, et al. Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome[J]. Nat Commun, 2018, 9(1): 1700. doi: 10.1038/s41467-018-03770-3
[6] LIU HY, LIU YY, YANG F, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer[J]. Nucleic Acids Res, 2020, 48(7): 3638. doi: 10.1093/nar/gkaa130
[7] LIU Z, LIU X, LI Y, et al. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression[J]. Cancer Manag Res, 2019, 11: 5317. doi: 10.2147/CMAR.S197733
[8] MACPHERSON L, ANOKYE J, YEUNG MM, et al. HBO1 is required for the maintenance of leukaemia stem cells[J]. Nature, 2020, 577(7789): 266. doi: 10.1038/s41586-019-1835-6
[9] KAHL M, BRIOLI A, BENS M, et al. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML[J]. Leukemia, 2019, 33(11): 2628. doi: 10.1038/s41375-019-0581-y
[10] O′DONNELL MR, ABBOUD CN, ALTMAN J, et al. NCCN clinical practice guidelines acute myeloid leukemia[J]. J Natl Compr Canc Netw, 2012, 10(8): 984. doi: 10.6004/jnccn.2012.0103
[11] 陈晓平, 吕娜, 李永辉, 等. 44例青少年及年轻成人急性淋巴细胞白血病患者治疗的回顾性分析[J]. 中国实验血液学杂志, 2016, 24(1): 14.
[12] 王蕾, 杨艳丽, 张凤, 等. DNMT3A R882突变在急性髓系白血病中的临床意义[J]. 蚌埠医学院学报, 2020, 45(3): 327.
[13] 陈矾, 焦晓飞, 张嘉宇, 等. N-乙酰基转移酶10的功能研究进展[J]. 华南国防医学杂志, 2017, 31(6): 76.
[14] OH TI, LEE YM, LIM BO, et al. Inhibition of nat10 suppresses melanogenesis and melanoma growth by attenuating microphthalmia-associated transcription factor(MITF) expression[J]. Int J Mol Sci, 2017, 18(9): 1924. doi: 10.3390/ijms18091924
[15] JIN G, XU M, ZOU M, et al. The processing, Gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: A systematic review[J]. Mol Ther Nucleic Acids, 2020, 20: 13. doi: 10.1016/j.omtn.2020.01.037
[16] 沈棋, 胡帅, 李峻, 等. N-乙酰基转移酶10在透明细胞性肾细胞癌中的表达及意义[J/CD]. 中华临床医师杂志(电子版), 2020, 14(3): 228. doi: 10.3877/cma.j.issn.1674-0785.2020.03.015
[17] TAN TZ, MIOW QH, HUANG RY, et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer[J]. EMBO Mol Med, 2013, 5(7): 1051. doi: 10.1002/emmm.201201823
[18] ZHANG H, HOU W, WANG HL, et al. GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion[J]. Clin Cancer Res, 2014, 20(17): 4717. doi: 10.1158/1078-0432.CCR-13-3477
[19] MA R, CHEN J, JIANG S, et al. Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition[J]. Am J Transl Res, 2016, 8(10): 4215.
[20] 任欣, 黄晓军, 江倩, 等. 去甲氧柔红霉素联合阿糖胞苷治疗初发急性髓系白血病的预后分析[J]. 中华血液杂志, 2018, 39(1): 15.
[21] 杜东芬, 朱丽霞, 王云贵, 等. 肾母细胞瘤1基因表达及其对急性髓系白血病患者预后的预测价值[J]. 浙江大学学报(医学版), 2019, 48(1): 55.
[22] XIA F, MA S, BIAN Y, et al. A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia[J]. Cancer Chemother Pharmacol, 2020, 85(3): 509. doi: 10.1007/s00280-019-03973-5
[23] 华湘黔, 周建华. 鼻腔鼻窦黏膜黑色素瘤中CD117, MITF及NAT10的表达及其与临床病理特征、预后的相关性[J]. 临床与病理杂志2019, 46(9): 1903.